Abbot Laboratories announced Financial Results for the period ended June 30, 2017.
The company’s Net Sales for the period increased by 10 percent in the outgoing year, whereas the Profit after Taxation for the Period decreased by 1 percent.
Gross Profit increased by 5 percent.
Comparison of Key Financials
Unconsolidated Profit and Loss Account – For the Six Months Ended |
|||
Key Financials |
Jan – June, 2017 |
Jan – Jun, 2016 |
% Change |
Amounts in PKR ‘000 |
|||
Net Sales |
12,057,546 |
10,966,427 |
10% |
Domestic |
11,377,105 |
10,363,552 |
10% |
Export |
680,441 |
602,875 |
13% |
CoGS |
7,510,737 |
6,639,710 |
13% |
Gross Profit |
4,546,809 |
4,326,717 |
5% |
Selling and Dist: Expenses |
1,844,256 |
1,631,905 |
13% |
Admin: Expenses |
208,714 |
210,745 |
-1% |
Other charges |
275,557 |
213,334 |
29% |
Other income |
231,007 |
221,848 |
4% |
Finance cost |
4,667 |
2,621 |
78% |
Profit before Taxation |
2,444,622 |
2,489,960 |
-2% |
Taxation |
766,656 |
789,138 |
-3% |
Net PAT |
1,677,966 |
1,700,822 |
-1% |
EPS – Basic and diluted |
17.14 |
17.37 |
-1% |
Company release on Earnings Report can be accessed here.